Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aztreonam for Inhalation in Non-CF Bronchiectasis
NCT01314716Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- Apr 2011
- Primary completion
- Apr 2013
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of aztreonam in Non-cystic fibrosis bronchiectasis (NCFB), sponsored by Gilead Sciences. Started Apr 2011; status: completed.
02
Drugs
aztreonam
03
Conditions
Non-cystic fibrosis bronchiectasis (NCFB)
Beyond the preview
Go deeper on NCT01314716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01314716.